Literature DB >> 17936498

Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB.

Nayara Delgado André1, Fernando L De Lucca.   

Abstract

It was suggested that PKR may act as a tumor suppressor. However, the results are still controversial. Here, we investigate the effect of PKR-specific short hairpin RNA (shRNA) expressing plasmids on pulmonary metastatic potential of B16-F10 melanoma cells in mice. Levels of both PKR mRNA and PKR protein were only significantly reduced in tumor cells transfected with plasmid-based PKR-specific shRNA. Injection of tumor cells transfected with PKR-specific shRNA expressing plasmid resulted in inhibition (85%) of metastatic nodules compared with control. Our results suggest that this effect is mediated by the transcription factor NF-kappaB. This study does not support the concept of PKR as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936498     DOI: 10.1016/j.canlet.2007.08.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Molecular mechanism by which palmitate inhibits PKR autophosphorylation.

Authors:  Hyunju Cho; Shayantani Mukherjee; Pratheeba Palasuberniam; Lisa Pillow; Betul Bilgin; Catherine Nezich; S Patrick Walton; Michael Feig; Christina Chan
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

2.  Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin.

Authors:  Anatoly Uzdensky; Svetlana Demyanenko; Mikhail Bibov; Svetlana Sharifulina; Oleg Kit; Yury Przhedetski; Viktoria Pozdnyakova
Journal:  Tumour Biol       Date:  2014-05-22

3.  Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy.

Authors:  Xiaolei Li; Zhiqiang Wu; Xiaojing An; Qian Mei; Miaomiao Bai; Leena Hanski; Xiang Li; Tero Ahola; Weidong Han
Journal:  Elife       Date:  2017-08-18       Impact factor: 8.140

4.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

5.  Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity.

Authors:  Abujiang Pataer; Stephen G Swisher; Jack A Roth; Christopher J Logothetis; Paul G Corn
Journal:  Cancer Biol Ther       Date:  2009-02-08       Impact factor: 4.742

6.  Dual activators of protein kinase R (PKR) and protein kinase R-like kinase PERK identify common and divergent catalytic targets.

Authors:  Huijun Bai; Ting Chen; Jie Ming; Hong Sun; Peng Cao; Dahlene N Fusco; Raymond T Chung; Michael Chorev; Qi Jin; Bertal H Aktas
Journal:  Chembiochem       Date:  2013-06-19       Impact factor: 3.164

7.  Double stranded RNA-dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma cells by activating STAT3.

Authors:  Xun Wang; Jia-Hong Dong; Wen-Zhi Zhang; Jian-Jun Leng; Shou-Wang Cai; Ming-Yi Chen; Xuerui Yang
Journal:  Oncol Lett       Date:  2014-09-24       Impact factor: 2.967

8.  Gelsolin suppresses gastric cancer metastasis through inhibition of PKR-p38 signaling.

Authors:  Xiangliang Yuan; Weiwei Wang; Junhua Li; Peiming Zheng; Ping Dong; Lei Chen; Yunlan Zhou; Guohua Xie; Dakang Xu; Yingbin Liu; Lisong Shen
Journal:  Oncotarget       Date:  2016-08-16

9.  Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2.

Authors:  Xuerui Yang; Christina Chan
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

10.  NDRG2 contributes to cisplatin sensitivity through modulation of BAK-to-Mcl-1 ratio.

Authors:  Soojong Park; Sang-Seok Oh; Ki Won Lee; Yeon-Kyeong Lee; Nae Yu Kim; Joo Heon Kim; Jiyun Yoo; Kwang Dong Kim
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.